Takahiro Iwamoto1, 3, Satomi Kita1, 5, Jin Zhang2, Mordecai P Blaustein2, Yuji Arai4, Shigeru Yoshida5, Koji Wakimoto6, Issei Komuro7
& Takeshi Katsuragi11
Department of Pharmacology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
2
Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
3
Department of Molecular Physiology, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan.
4
Department of Bioscience, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan.
5
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 330-8530, Japan.
6
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Osaka 532-8505, Japan.
7
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Correspondence should be addressed to Takahiro Iwamoto tiwamoto@cis.fukuoka-u.ac.jp
